A detailed history of Fin Trust Capital Advisors, LLC transactions in Incyte Corp stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 42 shares of INCY stock, worth $3,012. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42
Holding current value
$3,012
% of portfolio
0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$57.33 - $68.61 $2,407 - $2,881
42 New
42 $2,000
Q4 2023

Feb 13, 2024

BUY
$52.16 - $64.19 $3,651 - $4,493
70 New
70 $4,000
Q3 2020

Nov 10, 2020

SELL
$85.07 - $109.69 $42,535 - $54,845
-500 Closed
0 $0
Q2 2020

Sep 11, 2020

BUY
$74.18 - $108.93 $37,090 - $54,465
500 New
500 $52,000
Q2 2020

Aug 14, 2020

SELL
$74.18 - $108.93 $37,090 - $54,465
-500 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$63.18 - $85.97 $269,841 - $367,177
-4,271 Reduced 89.52%
500 $37,000
Q4 2019

Jan 23, 2020

SELL
$73.04 - $95.72 $22,642 - $29,673
-310 Reduced 6.1%
4,771 $417,000
Q3 2019

Oct 29, 2019

BUY
$72.82 - $86.52 $8,519 - $10,122
117 Added 2.36%
5,081 $377,000
Q2 2019

Aug 01, 2019

BUY
$73.52 - $88.7 $364,953 - $440,306
4,964 New
4,964 $422,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Fin Trust Capital Advisors, LLC Portfolio

Follow Fin Trust Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.